technetium tc 99m hydroxymethylene diphosphonate has been researched along with Low Bone Density in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 5 (83.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yamamoto, I | 1 |
Alvarez, L; de Osaba, MJ; Guañabens, N; Monegal, A; Parés, A; Peris, P; Pons, F; Roca, M; Rodés, J; Torra, M | 1 |
Bohuslavizki, KH; Brenner, W; Clausen, M; Henze, E; Sieweke, N; Tinnemeyer, S | 1 |
Antón, A; Caballero, O; Martínez, A; Serrano, J; Verdú, J | 1 |
Achong, DM; Mahoney, J | 1 |
Hasling, C; Mosekilde, L; Tågehøj Jensen, F; Tågehøj Jensen, PC | 1 |
1 review(s) available for technetium tc 99m hydroxymethylene diphosphonate and Low Bone Density
Article | Year |
---|---|
[Skeletal nuclear medicine].
Topics: Absorptiometry, Photon; Biomarkers; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Bone Neoplasms; Female; Humans; Male; Technetium Tc 99m Medronate; Tomography, Emission-Computed, Single-Photon | 1995 |
1 trial(s) available for technetium tc 99m hydroxymethylene diphosphonate and Low Bone Density
Article | Year |
---|---|
Etidronate versus fluoride for treatment of osteopenia in primary biliary cirrhosis: preliminary results after 2 years.
Topics: Absorptiometry, Photon; Bone Density; Bone Diseases, Metabolic; Drug Administration Schedule; Etidronic Acid; Female; Femur; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Lumbar Vertebrae; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sodium Fluoride; Technetium Tc 99m Medronate; Time Factors | 1997 |
4 other study(ies) available for technetium tc 99m hydroxymethylene diphosphonate and Low Bone Density
Article | Year |
---|---|
Quantification of diphosphonate uptake based on conventional bone scanning.
Topics: Adult; Aged; Bone and Bones; Bone Diseases, Metabolic; Case-Control Studies; Female; Humans; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tissue Distribution | 1997 |
[Reversible hyperparathyroid metabolic osteopathy secondary to parathyroid carcinoma].
Topics: Bone and Bones; Bone Diseases, Metabolic; Carcinoma; Contrast Media; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi; Time Factors | 1998 |
Demonstration of increased bone metabolism in melorheostosis by multiphase bone scanning.
Topics: Adult; Bone Diseases, Metabolic; Female; Femur; Humans; Melorheostosis; Patella; Radionuclide Imaging; Technetium Tc 99m Medronate; Tibia | 1991 |
Bisphosphonate whole body retention test: relations to bone mineralization rate, renal function and bone mineral content in osteoporosis and metabolic bone disorders.
Topics: Adult; Aged; Bone and Bones; Bone Diseases, Metabolic; Female; Humans; Kidney; Male; Middle Aged; Minerals; Osteoporosis; Regression Analysis; Technetium Tc 99m Medronate | 1987 |